Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10‐year experience at the University of Maryland Greenebaum Cancer Center
Dan P. Zandberg(University of Pittsburgh Medical Center), Kevin J. Cullen(University of Maryland, Baltimore), Robert E. Morales(University of Maryland, Baltimore), Scott E. Strome(Northwestern Medicine Lake Forest Hospital), R. Taylor(University of Oxford), Sandy Liu(University of Maryland, Baltimore), Ann B. Zimrin(University of Maryland, Baltimore), Lisa M. Schumaker, Jeffrey S. Wolf(University of Maryland, Baltimore), Robert A. Ord(University of Maryland, Baltimore), Joshua E. Lubek(University of Maryland, Baltimore), Mohan Suntharalingam(University of Maryland, Baltimore), Olga Goloubeva(University of Maryland, Baltimore)
Cited by 58
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
|Proceedings of the National Academy of Sciences|2004|767
Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|548